Developed by scientists at Oxford University, the new vaccine works by targeting protein cells inside the influenza A virus, instead of current vaccines that attack proteins on the outside of the flu virus.
According to Sarah Gilbert, head of the project at Oxford's Jenner Institute, this method is effective because proteins inside the virus are far more similar across all the influenza strains and are less likely to mutate.
In the first successful trial on humans, 11 healthy people were vaccinated and infected with the seasonal flu strain along with 11 non-vaccinated volunteers.
Source : cnn
Posts
